Bleomycin appears to be a useful drug to add to the therapeutic arsenal for the treatment of mycosis fungoides and reticulum cell lymphoma. Because of this drug's absence of hematological toxicity and the short duration of the remissions, we suggest its association with other cytostatics in the treatment of these two diseases.
de Bast C, Moriame N, Wanet J, Ledoux M, Achten G, Kenis Y. Bleomycin in Mycosis Fungoides and Reticulum Cell Lymphoma. Arch Dermatol. 1971;104(5):508–512. doi:10.1001/archderm.1971.04000230050007
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: